Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 25.03.2021.

#lifesciences
#pandemic
#treatment
#biotechnology
#COVID19
#coronavirus
#biospace
#clinicaltrials
#pharmaceuticals
#COVID

Career And Jobs

@biospace shared
On Mar 23, 2021
@OramedPharma Forms Joint Venture Company to Develop Oral COVID-19 Vaccines #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment https://t.co/1RCYcCLFJC
Open
Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines

Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines

Jerusalem’s clinical-stage pharmaceutical company Oramed Pharmaceuticals is forming a joint venture with Premas Biotech to develop novel oral COVID-19 vaccine candidates.

@BiotechWorld shared
On Mar 24, 2021
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO https://t.co/RVH2BgM5S1 https://t.co/XB6eesL5Ie
Open
Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Zimmermann replaces ex-Roche pRED chief as Inotrem CEO

Inotrem has named Sven Zimmermann as CEO. Zimmermann joins the inflammatory disease biotech after overseeing a series of deals at former employers including Novimmune’s asset sale to Sobi ...

@CALifeSciences shared
On Mar 24, 2021
Thank you🙏@rleuty_biotech @SFBusinessTimes for sharing about CA #lifesciences commitment to racial and social equity of the industry. We’re stronger, together. https://t.co/NwiXzgpIEt @LS_CaresBayArea #WeCommitToChange
Open
Biotech takes on racial and social equity. Are the efforts sustainable?

Biotech takes on racial and social equity. Are the efforts sustainable?

From holding Covid-19 vaccination events in San Francisco's Tenderloin neighborhood to building programs that target longstanding inequities, the Bay Area biotech industry is stepping into ...

@IAmBiotech shared
On Mar 19, 2021
A look at how the Biden administration’s agriculture policy agenda will impact the biotechnology sector and members of BIO: https://t.co/Au13PDVoWw
Open
What Biotech Can Expect From the Biden Administration's Agricultural Policy Agenda

What Biotech Can Expect From the Biden Administration's Agricultural Policy Agenda

With Katherine Tai confirmed unanimously by the Senate as the U.S. Trade Representative (USTR) and Secretary of Agriculture Tom Vilsack in place at the U.S. Department of Agriculture ...

@JohnCendpts shared
On Mar 22, 2021
You're flying along, the captain reports some turbulence and then whump! -- the plane implodes with 153 souls on board. $ODT Biotech today. https://t.co/1oiH2TDbzH
Open
Those NDA plans Odonate had for mid-'21? They're being scrapped — along with the entire biotech — in a sudden implosion

Those NDA plans Odonate had for mid-'21? They're being scrapped — along with the entire biotech — in a sudden implosion

Last summer, San Diego-based Odonate $ODT CEO Kevin Tang enthusiastically sought to bolster investors’ enthusiasm for the company with what the biotech called “a potential important ...

@biospace shared
On Mar 19, 2021
Deep Dive: Retaining Employees in the Life Sciences Industry https://t.co/UdlrtUGfEj https://t.co/dbfRLY4o45
Open
Deep Dive: Retaining Employees in the Life Sciences Industry

Deep Dive: Retaining Employees in the Life Sciences Industry

Are looking to relocate: 15% Khan and Jabbar, in a 2013 study published in Business and Management Research, noted, “the question of how to retain the existing employees is …

@GENbio shared
On Mar 19, 2021
. @FujifilmDiosyn Plans $2B Cell Culture Facility in Holly Springs, NC. What will the facility contain? https://t.co/Erz8pnW6bz https://t.co/0SANZUe4uq
Open
Fujifilm Diosynth Plans $2B Cell Culture Facility in Holly Springs, NC

Fujifilm Diosynth Plans $2B Cell Culture Facility in Holly Springs, NC

Two months after announcing plans to build a $2 billion cell culture manufacturing facility in the United States, Fujifilm has finally revealed the location—Holly Springs, NC, a 25-minute ...

@pharminews shared
On Mar 19, 2021
RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine https://t.co/E3pBumPOdq #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/lT6LTBj90X
Open
RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik  V vaccineMoscow, March 19, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign ...